OGWYARIXYXJMFM-UHFFFAOYSA-N
C71H43F6N3O2 — CID 139552797
Data last refreshed: (MolForge compound catalog, from PubChem)
About OGWYARIXYXJMFM-UHFFFAOYSA-N
OGWYARIXYXJMFM-UHFFFAOYSA-N (PubChem CID 139552797) has the molecular formula C71H43F6N3O2 and a molecular weight of 1084.13 g/mol. Its IUPAC name is 5-[5-([1]benzofuro[3,2-c]carbazol-5-yl)-3-(2-carbazol-9-ylpropan-2-yl)-2,4-bis[3-(trifluoromethyl)phenyl]phenyl]-[1]benzofuro[3,2-c]carbazole.
Molecular Properties
| Compound Name | OGWYARIXYXJMFM-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 139552797 |
| Molecular Formula | C71H43F6N3O2 |
| Molecular Weight | 1084.13 g/mol |
| Exact Mass | 1083.33 |
| IUPAC Name | 5-[5-([1]benzofuro[3,2-c]carbazol-5-yl)-3-(2-carbazol-9-ylpropan-2-yl)-2,4-bis[3-(trifluoromethyl)phenyl]phenyl]-[1]benzofuro[3,2-c]carbazole |
| SMILES | CC(C)(c1c(-c2cccc(C(F)(F)F)c2)c(-n2c3ccccc3c3c4oc5ccccc5c4ccc32)cc(-n2c3ccccc3c3c4oc5ccccc5c4ccc32)c1-c1cccc(C(F)(F)F)c1)n1c2ccccc2c2ccccc21 |
| InChI | InChI=1S/C71H43F6N3O2/c1-69(2,80-54-29-11-3-21-44(54)45-22-4-12-30-55(45)80)66-62(40-17-15-19-42(37-40)70(72,73)74)58(78-52-27-9-5-25-50(52)64-56(78)35-33-48-46-23-7-13-31-60(46)81-67(48)64)39-59(63(66)41-18-16-20-43(38-41)71(75,76)77)79-53-28-10-6-26-51(53)65-57(79)36-34-49-47-24-8-14-32-61(47)82-68(49)65/h3-39H,1-2H3 |
| InChIKey | OGWYARIXYXJMFM-UHFFFAOYSA-N |
| XLogP | 20.94 |
| TPSA | 41.07 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 82 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1084.13 |
| LogP ≤ 5 | 20.94 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139552797 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.